SOURCE: OneMedPlace

OneMedPlace

October 26, 2009 11:35 ET

50 Companies Already Confirmed to Present at 'The OneMedForum 2010 Finance Conference'

Third Annual Event for Emerging Public and Private Healthcare Companies to Be Held January 12-14, 2010, in San Francisco

NEW YORK, NY--(Marketwire - October 26, 2009) - OneMedPlace announced today that it has finalized its program and has selected the first-50 healthcare and life science companies to present at its "OneMedForum 2010" finance conference, to be held January 12-14, 2010, in San Francisco at the Sir Francis Drake Hotel. The goal of the annual OneMedForum event is to connect emerging healthcare/life science companies with healthcare/life science-focused investors. OneMedForum will include panel sessions, company presentations and numerous networking opportunities.

"We are very pleased with the quality of the companies that will be presenting," said Brett Johnson, President of OneMedPlace, organizer of the OneMedForum event. "Thanks to the efforts of our advisory board, we have been able to identify a strong and growing roster of very promising companies."

Organizers are well ahead of previous years and on track to double the size of the event again in 2010. Presenting companies as of Oct. 20th include: Access Pharmaceuticals (BB), ADVENTRX Pharmaceuticals (AMEX), Aureon Laboratories (Private), BioDelivery Sciences International (Nasdaq), BioSante Pharmaceuticals (Nasdaq), CardioPolymers (Private), Cardium Therapeutics (AMEX), Catheter Connections (Private), Clarient (Nasdaq), Conceptus (Nasdaq), Cyclacel Pharmaceuticals (Nasdaq), Cytori Therapeutics (Nasdaq), CytRx (Nasdaq), Data Physics Research (Private), DataTrak International (BB), Elemé Medical (Private), Envisioneering Medical (Private), EpiCept (Nasdaq), Health-Link Europe (Private), Hepregen (Private), ImmunoCellular Therapeutics (BB), Impres Medical (Private), Inovio Biomedical (AMEX), Invendo Medical (Private), Kosin Technologies (Private), Lucid (Private), MedicaSafe (Private), Micrus Endovascular (Nasdaq), Minnow Medical (Private), MyoScience (Private), Nabi Biopharmaceuticals (Nasdaq), NeoPharm (Nasdaq), NovaBay Pharmaceuticals (AMEX), NuVue Therapeutics (Private), Oculus Innovative Sciences (Nasdaq), OPKO Health (AMEX), Oxygen Biotherapeutics (BB), Patriot Data Solutions Group (BB), Peregrine Pharmaceuticals (Nasdaq), Pico-Tesla Magnetic Therapies (Private), Pressure BioSciences, (Nasdaq), Quintessence Biosciences (Private), ScyFIX (Private), Senesco Technologies (AMEX), Spherix (Nasdaq), SRS Medical (Private), Telcare (Private), TRACON Pharmaceuticals (Private), Woodside Logic (Private), and Xlumena (Private).

Regarding the growing and widespread popularity of the OneMedForum finance conference, Johnson stated: "A very large percentage of major investors are in San Francisco during the first week of January. We offer a venue for the smaller-sized, innovative companies with disruptive technologies companies to easily connect with investors who are looking to identify 'the next big thing' in healthcare."

To present at the OneMedForum event, contact Justin Schreiber at 212-734-1008 or send an email to Justin Schreiber at jschreiber@onemedplace.com.

About OneMedForum

OneMedForum is an annual financial conference organized by OneMedPlace and its partners. Its principle aim is to connect the most promising emerging healthcare and life science companies with investors, analysts, business development executives and industry partners. More than 100 smaller public and private companies in the areas of medical devices and diagnostics, biotechnology, pharmaceuticals, healthcare IT and healthcare services will make presentations to an audience of 500+ attendees. Panel discussions also have been organized and will focus on the therapeutics areas likely to receive the most attention from investors in the year to come.

Contact Information